Shafiq S, Dervash MA. Coronary artery disease: the culprit behind the trounced productivity with special reference to India. Int J Biotechnol Biomedical Sci. 2020;6(1).

Lockhart PB, Sun YP. Diseases of the cardiovascular system. Burket’s Oral Med. 2021:505–52.

Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2024;149(8):e347–913.

Article  PubMed  Google Scholar 

Arafa A, Lee H-H, Eshak ES, Shirai K, Liu K, Li J, et al. Modifiable risk factors for cardiovascular disease in Korea and Japan. Korean Circulation J. 2021;51(8):643.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. lancet. 2020;396(10258):1204–22.

Article  Google Scholar 

O’Meara JG, Kardia SLR, Armon JJ, Brown CA, Boerwinkle E, Turner ST. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med. 2004;164(12):1313–8.

Article  PubMed  Google Scholar 

Egan BM, Li J, Qanungo S, Wolfman TE. Blood pressure and cholesterol control in hypertensive hypercholesterolemic patients: national health and nutrition examination surveys 1988–2010. Circulation. 2013;128(1):29–41.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jackson R, Lawes CMM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual’s absolute cardiovascular risk. Lancet. 2005;365(9457):434–41.

Article  PubMed  CAS  Google Scholar 

Trimarco V, Izzo R, Morisco C, Mone P, Virginia Manzi M, Falco A, et al. High HDL (high-density lipoprotein) cholesterol increases cardiovascular risk in hypertensive patients. Hypertension. 2022;79(10):2355–63.

Article  PubMed  CAS  Google Scholar 

Gupta P, Patel P, Štrauch B, Lai FY, Akbarov A, Marešová V, et al. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017;69(6):1113–20.

Article  PubMed  CAS  Google Scholar 

Kolandaivelu K, Leiden BB, O’Gara PT, Bhatt DL. Non-adherence to cardiovascular medications. Eur Heart J. 2014;35(46):3267–76.

Article  PubMed  CAS  Google Scholar 

Wald DS, Law M, Morris JK, Bestwick JP, Wald NJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122(3):290–300.

Article  PubMed  Google Scholar 

Kim W, Chang K, Cho EJ, Ahn JC, Yu CW, Cho KI, et al. A randomized, double-blind clinical trial to evaluate the efficacy and safety of a fixed‐dose combination of amlodipine/rosuvastatin in patients with dyslipidemia and hypertension. J Clin Hypertens. 2020;22(2):261–9.

Article  CAS  Google Scholar 

Jin X, Kim MH, Han KH, Hong SJ, Ahn JC, Sung JH, et al. Efficacy and safety of co-administered telmisartan/amlodipine and rosuvastatin in subjects with hypertension and dyslipidemia. J Clin Hypertens. 2020;22(10):1835–45.

Article  CAS  Google Scholar 

Park S, Hwang D, Kang J, Han J-K, Yang H-M, Park KW, et al. Efficacy and safety of triple therapy of telmisartan/amlodipine/rosuvastatin in patients with dyslipidemia and hypertension: a multicenter randomized clinical trial. Curr Therapeutic Res. 2024;100:100735.

Article  Google Scholar 

Hong SJ, Jeong HS, Cho J-M, Chang K, Pyun WB, Ahn Y, et al. Efficacy and safety of triple therapy with telmisartan, amlodipine, and rosuvastatin in patients with dyslipidemia and hypertension: the Jeil telmisartan, amlodipine, and rosuvastatin randomized clinical trial. Clin Ther. 2019;41(2):233–48.

Article  PubMed  CAS  Google Scholar 

Kim T-S, Rha S-W, Kim S-Y, Park D-G, Sung K-C, Yoon M-H, et al. Efficacy and tolerability of telmisartan/amlodipine and rosuvastatin coadministration in hypertensive patients with hyperlipidemia: a phase III, multicenter, randomized, double-blind study. Clin Ther. 2019;41(4):728–41.

Article  PubMed  CAS  Google Scholar 

Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. lancet. 2005;365(9455):217–23.

Article  PubMed  Google Scholar 

Neal B. Blood Pressure lowering treatment trialists’ collaboration. Effects of ACE inhibitor, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet. 2000;9(356):1955–64.

Google Scholar